GenoPredicta™ Sample Report
The current card carries the ASH poster blurb; it should describe an example GenoPredicta report.
Related Resources
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
Highlights:
•EloLenDex is associated with 4-year PFS of 89% in patients with high-risk SMM
•Immune reactivity, post-therapy immune normalization are associated with longer PFS
•Higher abundance of GZMK+ cytotoxic T cells is associated with longer PFS
•Blood-based immune profiling detects immune dysregulation associated with disease
Whole genome sequencing of multiple myeloma genomes with a novel clinical assay enables identification of genetic alterations underlying immunotherapy resistance — AACR 2026
Presented at AACR; demonstrates GenoPredicta’s whole-genome sequencing from as few as ~50 circulating tumor cells, with 100% concordance to bone marrow and FISH and detection of subclonal, resistance-associated alterations from blood.
GenoPredicta™ Specimen Collection Instructions
Step-by-step prep, collection, packaging, and shipping instructions for blood or bone marrow samples.
Predicta Newsletter
Enter your email address to subscribe.
Enter Email Address:
Predicta Biosciences
750 Main Street, Lab 413
Cambridge, MA 02139